Table 3.
Event | FOLFOXIR-Bev | XELOXIRI-Bev | P value |
---|---|---|---|
Neutropenia | 32 (46.4%) | 15 (21.7%) | 0.002 |
Febrile neutropenia | 8 (11.6%) | 5 (7.2%) | 0.382 |
Diarrhea | 14 (20.3%) | 7 (10.1%) | 0.097 |
Stomatitis | 9 (13.0%) | 4 (5.8%) | 0.145 |
Nausea | 3 (4.3%) | 2 (2.9%) | 0.649 |
Vomiting | 6 (8.7%) | 2 (2.9%) | 0.145 |
Asthenia | 10 (14.5%) | 6 (8.7%) | 0.228 |
Peripheral neuropathy | 11 (15.9%) | 0 | 0.001 |
Hypertension | 4 (5.8%) | 1 (1.4%) | 0.172 |
Venous thromboembolism | 5 (7.2%) | 4 (5.8%) | 0.730 |
Serious adverse events | 14 (20.3%) | 12 (17.4%) | 0.663 |